n (% of total events) | |
---|---|
Number of NADC events | 880 (100.0) |
Lung cancer | 140 (15.9) |
Hodgkin’s lymphoma | 112 (12.7) |
Anal cancer | 79 (9.0) |
Head and neck cancers | 71 (8.1) |
Liver cancer | 59 (6.7) |
Prostate | 57 (6.5) |
Breast cancer | 43 (4.9) |
Malignant melanoma | 31 (3.5) |
Colon cancer | 26 (3.0) |
Bladder cancer | 21 (2.4) |
Rectal | 20 (2.3) |
Gynecological cancers* | 14 (1.6) |
Stomach | 13 (1.5) |
Penile cancer | 12 (1.4) |
Kidney cancers | 12 (1.4) |
Acute myeloid leukemia | 11 (1.3) |
Metastasis of adenocarcinoma | 9 (1.0) |
Testicular | 9 (1.0) |
Lip cancer | 6 (0.7) |
Uterus | 5 (0.6) |
Brain cancer | 5 (0.6) |
Multiple myeloma | 5 (0.6) |
Metastasis of other cancer type | 5 (0.6) |
Metastasis of squamous cell carcinoma | 5 (0.6) |
Metastasis unspecified | 4 (0.5) |
Chronic lymphatic leukemia | 2 (0.2) |
Chronic myeloid leukemia | 2 (0.2) |
Connective tissue cancer | 2 (0.2) |
Bone cancer | 1 (0.1) |
Acute lymphatic leukemia | 1 (0.1) |
Leukemia unspecified | 1 (0.1) |
Type unknown | 8 (0.9) |
Unknown primary cancer | 7 (0.8) |
Other** | 82 (9.3) |
Number of ADC events | 621 (100.0) |
Kaposi’s sarcoma | 331 (53.3) |
Non-Hodgkin’s lymphoma | 251 (40.4) |
Cervical carcinoma | 46 (7.4) |